First, while our integrated bioinformatics and machine learning approach strongly identified ARL2 as a common diagnostic biomarker, the precise causal relationship between ARL2 dysregulation and the pathogenesis of sleep disorders (SD) and ischemic stroke (IS) remains to be fully elucidated. This evidence concerns the gene ARL2 and Salla disease.